High BMI Associated with Improved OS Following Atezolizumab in Advanced NSCLC Treatment
January 21, 2020
A recent study indicated that baseline BMI should be considered as a stratification factor in future immune checkpoint inhibitor therapy trials.
Recent Content
Activation of Apelin Signaling Decreases VEGF Inhibitor Efficacy in Ovarian Cancer Treatment
January 21, 2020
A recent study suggested the activation of apelin/APJ signaling decreased efficacy in VEGF treatment, while bevacizumab decreased disease-free survival rates with increased expression of apelin in patients of ovarian cancer.
FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma
January 21, 2020
The agency granted the immunoconjugate targeting B-cell maturation antigen priority review to belantamab mafodotin for the treatment of heavily pre-treated patients with relapsed or refractory multiple myeloma.
FDA Grants Fast Track Designation to Oncoprex Combination for NSCLC
January 21, 2020
Oncoprex in combination with osimertinib received fast track designation from the FDA to treat patients with non-small cell lung cancer.
Early-Onset Gastric Cancer Suggested to be Genetically and Clinically Distinct
January 20, 2020
Incidence of early-onset gastric cancer has steadily increased in the US, now comprising >30% of new gastric cancer cases today, causing researchers to try and discover what makes this disease type unique.
Online and Digital Videos Can Play Key Role in Cancer Education
January 20, 2020
Research shows that digital videos led to increased knowledge and interventions, but access for vulnerable populations must be improved.
Greater Observance of Cancer Prevention Recommendations Linked to Decreased CRC Risk
January 20, 2020
Similar health risks for colorectal cancer were observed in both African Americans and whites, though this study indicated that benefit from greater adherence may be higher at the population level for African Americans.
Defining the Landscape of Mutations Present in Pediatric Acute Lymphoblastic Leukemia
January 20, 2020
This research has the potential to aid in the development of new strategies for early detection of relapse in pediatric patients with ALL, and the development of treatments to counter clinical occurrence.
Obesity in Early-Stage Breast Cancer May Increase Risk for Cardiotoxicity
January 19, 2020
These results highlight the increased prevalence of cardiovascular risk factors in these patients, and the need for personalized risk assessments for cardiac complications following cardiotoxic therapies.
DCE-MRI Scans May Help to Predict 10-Year Breast Cancer Recurrence
January 18, 2020
This data could present a non-invasive option for characterizing tumor heterogeneity to improve personalized prognosis and treatment of patients with breast cancer.
